Skip to content
OpenCapital
Get started

UFP Technologies UFPT Lease Liability Payments - Remainder of Fiscal Year

Lease Liability Payments - Remainder of Fiscal Year at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's lease liability payments - remainder of fiscal year.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UFP Technologies's lease liability payments - remainder of fiscal year?
UFP Technologies (UFPT) reported lease liability payments - remainder of fiscal year of $17K in Q1 2026.
What does lease liability payments - remainder of fiscal year mean?
The contractual cash obligations for operating and finance leases due within the remaining months of the current fiscal year. This provides a short-term view of the company's fixed lease commitments. It is a critical component for assessing near-term liquidity and cash flow requirements.